Proinflammatory lymphokine and hormone levels in men with type 2 diabetes mellitus

Proinflammatory lymphokine and hormone levels in men with type 2 diabetes mellitus

Background. It is well known that the development of insulin resistance as the main factor of metabolic syndrome (MS) is accompanied by an imbalance in the cytokine system: an increase in the level of interleukin6 (ІЛ6), tumor necrosis factorα (TNFα) and a decrease in ІЛ10, ІЛ4. One of the cau...

Full description

Bibliographic Details
Main Author:	V.E. Luchytskiy
Format:	Article
Language:	English
Published:	Publishing House Zaslavsky 2019-02-01
Series:	Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:	diabetes mellitus metabolic syndrome lymphokines hormones androgen deficiency
Online Access:	http://iej.zaslavsky.com.ua/article/view/158689

Similar Items

Hormonal and metabolic characteristic of androgen deficiency and its correction by testosterone in men with type 1 diabetes mellitusundergoing programmed hemodialysis
by: Alexander Evgen'evich Lepetukhin, et al.
Published: (2010-03-01)

Endocrine Disrupting Chemicals Mediated through Binding Androgen Receptor Are Associated with Diabetes Mellitus
by: Sugunadevi Sakkiah, et al.
Published: (2017-12-01)

Lymphokine-activated killer cell transplantation after anti-cancer treatment in two aged cats
by: Noritaka Maeta, et al.
Published: (2019-05-01)

Evaluation of Hypothalamic-Pituitary-Gonadal Axis in Men with Metabolic Syndrome and Androgen Deficiency Depending on Age
by: S.I. Ismailov, et al.
Published: (2012-02-01)

Blood concentrations of endothelin, interleukins 6 and 10 in men with diabetes mellitus
by: E.V. Luchytskiy, et al.
Published: (2021-06-01)

INTEGRATED ASSESSMENT OF THE SUBSTANTIATION FOR MEDICAL CARE TECHNOLOGIES IN TYPE 2 DIABETES PATIENTS WITH ANDROGEN DEFICIENCY
by: V. N. Vasilkova, et al.
Published: (2017-08-01)

Short-term stimulation with interleukin (IL)-4 enhances purified protein derivative-induced production of an eosinophil chemotactic lymphokine, but suppresses IL-5 production
by: Takehiko Nishiyama, et al.
Published: (1998-01-01)

Association of the polymorphism in the androgen receptor gene and endothelial function in men with type 2 diabetes
by: Irina Alekseevna Khripun, et al.
Published: (2015-10-01)

Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
by: Galina Afanas'evna Melnichenko, et al.
Published: (2017-06-01)

A pathway level analysis of PFAS exposure and risk of gestational diabetes mellitus
by: Rahel L. Birru, et al.
Published: (2021-05-01)

Diabetes duration and thyroid stimulating hormone levels in children with type 1 diabetes mellitus
by: Nur Rochmah, et al.
Published: (2018-04-01)

The occurrence of skin lesions in patients with androgenization syndromes including the analysis of the results of hormonal tests
by: Mirela Niedzielska, et al.
Published: (2017-08-01)

A study to evaluate the prevalence of hypogonadism in Indian males with Type-2 diabetes mellitus
by: Pankaj Kumar Agarwal, et al.
Published: (2017-01-01)

Effect of duration of diabetes mellitus on the prevalence of diabetic retinopathy in patients with type 2 diabetes and metabolic syndrome
by: Rena kyzy Guseynova, et al.
Published: (2010-06-01)

The prevalence and associations of low testosterone levels and erectile dysfunction in a male diabetic urban population
by: Kemp, Tanja
Published: (2015)

Correlation between sex hormone levels and bone metabolic markers and bone mineral density in male patients with type 2 diabetes mellitus
by: Yu-Lian Lu, et al.
Published: (2016-10-01)

EFFECT OF TESTOSTERONE REPLACEMENT THERAPY ON QUALITY OF LIFE OF TYPE 2 DIABETES PATIENTS AND ANDROGEN DEFICIENCY
by: V. N. Vasilkova, et al.
Published: (2016-03-01)

The relationships of sex hormone‐binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome
by: Pomme I. H. G. Simons, et al.
Published: (2021-07-01)

Vitamin D status, calcium, magnesium and parathyroid hormone levels in patients with diabetes mellitus
by: Kh.M. Shchubelka, et al.
Published: (2017-11-01)

Testosterone undecanoate effects on cardiovascular risk factors in men with metabolic syndrome
by: A. L. Vertkin, et al.
Published: (2008-10-01)

The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
by: Galina A. Melnichenko, et al.
Published: (2019-06-01)

Diagnostic value of hormonal, lipid and ultrasonographic myocardial parameters in metabolic syndrome complicated by chronic coronary artery disease and type 2 diabetes mellitus
by: R.Ya. Dutka, et al.
Published: (2021-04-01)

Influence of hypothyroidism in men on androgenic function
by: T.I. Krytskyi
Published: (2018-11-01)

Impact of hormone replacement therapy on cardiac metabolic indicators in men with high cardiovascular risk and hypogonadism
by: M. N. Mamedov, et al.
Published: (2014-12-01)

Impact of hormone replacement therapy on cardiac metabolic indicators in men with high cardiovascular risk and hypogonadism
by: M. N. Mamedov, et al.
Published: (2014-12-01)

Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency
by: Han Hyuk Lim, et al.
Published: (2010-10-01)

Is it possible to achieve sustained remission or cure of type 2 diabetes mellitus in the 21st century?
by: M V Shestakova, et al.
Published: (2017-10-01)

The Network of Cytokines in Brain Metastases
by: Jawad Fares, et al.
Published: (2021-01-01)

No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study
by: Paolo Beck-Peccoz, et al.
Published: (2019-12-01)

Plasma Glucose and Serum Ceruloplasmin in Metabolic Syndrome and Diabetes Mellitus Type 2
by: Ashok Kumar Jeppu, et al.
Published: (2016-04-01)

The effects of menopausal hormone therapy on proinflammatory cytokines and immunoglobulins in perimenopausal patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease (COPD)
by: A S Panevina, et al.
Published: (2018-10-01)

Adoptive immunotherapy with interleukin-2 and lymphokine-activated killers in patients with malignant neoplasms of the female reproductive system (a review of literature)
by: A. N. Gritsai, et al.
Published: (2015-01-01)

Effect of the co-administration of glucose with morphine on glucoregulatory hormones and causing of diabetes mellitus in rats
by: Maryam Radahmadi, et al.
Published: (2016-01-01)

Pathogenetic correlations androgen deficiency and uronephrological kidneys diseases at men (the literary review)
by: I. A. Tyuzikov
Published: (2014-11-01)

Pathogenetic correlations androgen deficiency and uronephrological kidneys diseases at men (the literary review)
by: I. A. Tyuzikov
Published: (2014-11-01)

Impaired Cortisol and Growth Hormone Counterregulatory Responses among Severe Hypoglycemic Patients with Type 2 Diabetes Mellitus
by: Young A Rhyu, et al.
Published: (2019-06-01)

Frequency of Metabolic Syndrome in cases with Type 2 Diabetes Mellitus
by: Danial Qureshi, et al.
Published: (2018-04-01)

Correlation of hypothyroidism and androgen deficiency in men of different periods of mature age
by: T.I. Krytskyi, et al.
Published: (2018-02-01)

Graves' Disease and Diabetes Mellitus
by: M. Suttan Assin, et al.
Published: (2019-01-01)

Microcirculatory function in patients with arterial hypertension, metabolic syndrome and diabetes mellitus
by: A. P. Vasilyev, et al.
Published: (2008-10-01)